year 11, Issue 4 (September - October 2017)                   Iran J Med Microbiol 2017, 11(4): 57-63 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fatehi T, Anvari M, Ranji N. Investigating Antibiotic Resistance and The Frequency of SHVand TEM Extended Expecterum Beta Lactamase Genes in klebsiella penumoniea Isolated from Blood Samples of Neonates Admitted to Some Health Centers in Rasht. Iran J Med Microbiol 2017; 11 (4) :57-63
URL: http://ijmm.ir/article-1-642-en.html
1- Department of Biology, faculty of Sciences, Rasht Branch, Islamic Azad University, Rasht, Iran
2- Department of Biology, faculty of Sciences, Rasht Branch, Islamic Azad University, Rasht, Iran , anvari@iaurasht.ac.ir
Abstract:   (7003 Views)

Background and Aims: Klebsiella pneumoniae is one of the most common causes of nosocomial infections. The aim of this study was to determine the frequency of the blaTEM and blaSHV genes in K. pneumoniae strains isolated from blood samples of neonates admitted to some health centers in Rasht.
Materials and Methods: In this study, 163 isolates from blood samples were taken during 6 months from July to December 2015. Antibiotic susceptibility was conducted by disc diffusion method and screening test using combination disc method. Also, the presence of blaTEM and blaSHV genes were studied using PCR method.
Results and Conclusions: Among the total of 163 cultured blood samples, 16 were positive. Only 3 strains were diagnosed as K. pneumonia (18.75%). Two out of 3 positive samples (67%) were identified as the ESBLproducers in the primary screening test. The isolated K. pneumonia had the highest resistance to penicillin and amoxicillin (100%) and the lowest resistance to imipenem and ceftazidime (33%). The results of PCR on 3 samples showed that all the 3 isolates (100%) contained SHV gene, 1 strain (33.3%) had TEM gene and 1 case (33.3%) had both TEM and SHV genes simultaneously. In conclusion the horizontal gene transfer among bacteria in hospitals and clinical centers and the patterns of antibiotic useage should receive more attention.

Full-Text [PDF 553 kb]   (2044 Downloads)    
Type of Study: Brief Original Article | Subject: Molecular Microbiology
Received: 2016/11/20 | Accepted: 2017/03/5 | ePublished: 2017/09/12

References
1. 1. Falade AG, Ayede AI. Epidemiology, aetiology and management of childhood acute community-acquired pneumonia in developing countries--a review. African journal of medicine and medical sciences. 2011 Dec;40(4):293-308. [PubMed]
2. 2. Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. The Korean journal of internal medicine. 2012 May 31;27(2):128-42. [DOI] [PubMed]
3. 3. Marra AR, Wey SB, Castelo A, Gales AC, Cal RG, do Carmo Filho JR, Edmond MB, Pereira CA. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum β-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC infectious diseases. 2006 Feb 14;6(1):1. [DOI] [PubMed]
4. 4. Alves MS, da Silva Dias RC, de Castro AC, Riley LW, Moreira BM. Identification of clinical isolates of indole-positive and indole-negative Klebsiella spp. Journal of clinical microbiology. 2006 Oct 1;44(10):3640-6. [DOI] [PubMed]
5. 5. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. Journal of Antimicrobial Chemotherapy. 2010 Apr 8:dkq108. [DOI] [PubMed]
6. 6. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamases: a last frontier for β-lactams?. The Lancet infectious diseases. 2011 May 31;11(5):381-93. [DOI]
7. 7. Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrobial Agents and Chemotherapy. 1991 Sep;35(9):1697. [DOI] [PubMed]
8. 8. Howard C, Van Daal A, Kelly G, Schooneveldt J, Nimmo G, Giffard PM. Identification and minisequencing-based discrimination of SHV β-lactamases in nosocomial infection-associated Klebsiella pneumoniae in Brisbane, Australia. Antimicrobial agents and chemotherapy. 2002 Mar 1;46(3):659-64. [DOI]
9. 9. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem Resistance Among Klebsiella pneumoniae Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns. Infection Control & Hospital Epidemiology. 2009 Jul 1;30(07):666-71. [DOI] [PubMed]
10. 10. Clinical Laboratory and Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 15th informational Supplement (M100-s15). National Committee for Clinical Laboratory Standards. Wayne, Pa: 2010.
11. 11. Rasheed JK, Tenover FC. 2003. Detection and characterization of antimicrobial resistance genes in bacteria In: Murray, 8th ed, Baron EJ, PP 1196-1212.
12. 12. MuKherjee M, BaSu S, MuKherjee SK, MajuMder M. Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E. Coli which were isolated from hospitalized patients in Kolkata, India. J Clin Diagn Res. 2013 Mar 1;7(3):449-53. [PubMed]
13. 13. Derakhshan S, Najar Peerayeh S, Fallah F, Bakhshi B, Rahbar M, Mohammad-Zadeh M. Identification of Extended Spectrum Beta-lactamase producing Klebsiella pneumoniae isolated from Intensive Care Unit (ICU) patients in three hospitals in Tehran. Infection, Epidemiology and Medicine. 2013 Sep 1;1(1):9-13..
14. 14. Ali AM, Rafi S, Qureshi AH. Frequency of extended spectrum beta lactamase producing gram negative bacilli among clinical isolates at clinical laboratories of Army Medical College, Rawalpindi. Proteus. 2004;2(11):25.
15. 15. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended-spectrum β-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. Journal of Medical Microbiology. 2003 May 1;52(5):421-5. [DOI] [PubMed]
16. 16. Qureshi MA, Asif NA, Baig SU. Evaluation of extended spectrum β-lactamase mediated resistance in Escherichia coli and Klebsiella in urinary tract infection at a tertiary care hospital. Biomedica. 2013 Apr;29:78.
17. 17. Udomsantisuk N, Nunthapisud P, Tirawatanapong T, Dansuputra M. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae. Journal of the Medical Association of Thailand= Chotmaihet thangphaet. 2011 Dec;94(12):1504-12.
18. 18. Doosti A, Pourabbas M, Arshi A, Chehelgerdi M, Kabiri H. TEM and SHV Genes in Klebsiella pneumoniae Isolated from Cockroaches and Their Antimicrobial Resistance Pattern. Osong public health and research perspectives. 2015 Feb 28;6(1):3-8. [DOI] [PubMed]
19. 19. Riyahi Zaniani F, Meshkat Z, Naderi Nasab M, Khaje-Karamadini M, Ghazvini K, Rezaee A, Esmaily H, Darban Hoseini M. The prevalence of TEM and SHV genes among extended-spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae. Iranian journal of basic medical sciences. 2012 Jan 1;15(1):654-60.
20. 20. Palucha A, Mikiewicz B, Hryniewicz W, Gniadkowski M. Concurrent outbreaks of extended-spectrum β-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. Journal of Antimicrobial Chemotherapy. 1999 Oct 1;44(4):489-99. [DOI] [PubMed]
21. 21. Niitsuma K, Saitoh M, Kojimabara M, Kashiwabara N, Aoki T, Tomizawa M, Maeda J, Kosenda T. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated in Fukushima Prefecture]. The Japanese journal of antibiotics. 2001 Feb;54(2):79-87. [PubMed]
22. 22. Kesselov M, Kolár M, Sauer P, Koukalová D, Petrzelová J, Vágnerová I, Kohnová I, Kantor L, Urbánek K. [Molecular biology characteristics of ESBL-positive strains of Klebsiella pneumoniae collected in the Neonatal Unit of the Teaching Hospital in Olomouc]. Klinicka mikrobiologie a infekcni lekarstvi. 2005 Feb;11(1):20-4.
23. 23. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G, Italian ESBL Study Group. Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs. Antimicrobial Agents and Chemotherapy. 2002 Jan 1;46(1):196-202. [DOI] [PubMed]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc